206 related articles for article (PubMed ID: 36006066)
1. Quantib Prostate Compared to an Expert Radiologist for the Diagnosis of Prostate Cancer on mpMRI: A Single-Center Preliminary Study.
Faiella E; Vertulli D; Esperto F; Cordelli E; Soda P; Muraca RM; Moramarco LP; Grasso RF; Beomonte Zobel B; Santucci D
Tomography; 2022 Aug; 8(4):2010-2019. PubMed ID: 36006066
[TBL] [Abstract][Full Text] [Related]
2. Bridging the experience gap in prostate multiparametric magnetic resonance imaging using artificial intelligence: A prospective multi-reader comparison study on inter-reader agreement in PI-RADS v2.1, image quality and reporting time between novice and expert readers.
Forookhi A; Laschena L; Pecoraro M; Borrelli A; Massaro M; Dehghanpour A; Cipollari S; Catalano C; Panebianco V
Eur J Radiol; 2023 Apr; 161():110749. PubMed ID: 36812699
[TBL] [Abstract][Full Text] [Related]
3. Biparametric prostate MRI: impact of a deep learning-based software and of quantitative ADC values on the inter-reader agreement of experienced and inexperienced readers.
Cipollari S; Pecoraro M; Forookhi A; Laschena L; Bicchetti M; Messina E; Lucciola S; Catalano C; Panebianco V
Radiol Med; 2022 Nov; 127(11):1245-1253. PubMed ID: 36114928
[TBL] [Abstract][Full Text] [Related]
4. Deep-Learning-Based Artificial Intelligence for PI-RADS Classification to Assist Multiparametric Prostate MRI Interpretation: A Development Study.
Sanford T; Harmon SA; Turkbey EB; Kesani D; Tuncer S; Madariaga M; Yang C; Sackett J; Mehralivand S; Yan P; Xu S; Wood BJ; Merino MJ; Pinto PA; Choyke PL; Turkbey B
J Magn Reson Imaging; 2020 Nov; 52(5):1499-1507. PubMed ID: 32478955
[TBL] [Abstract][Full Text] [Related]
5. Artificial Intelligence in Magnetic Resonance Imaging-based Prostate Cancer Diagnosis: Where Do We Stand in 2021?
Suarez-Ibarrola R; Sigle A; Eklund M; Eberli D; Miernik A; Benndorf M; Bamberg F; Gratzke C
Eur Urol Focus; 2022 Mar; 8(2):409-417. PubMed ID: 33773964
[TBL] [Abstract][Full Text] [Related]
6. Prostate Magnetic Resonance Imaging Interpretation Varies Substantially Across Radiologists.
Sonn GA; Fan RE; Ghanouni P; Wang NN; Brooks JD; Loening AM; Daniel BL; To'o KJ; Thong AE; Leppert JT
Eur Urol Focus; 2019 Jul; 5(4):592-599. PubMed ID: 29226826
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic pathway of the biopsy-naïve patient suspected for prostate cancer: Real-life scenario when multiparametric Magnetic Resonance Imaging is not centralized.
Bertolo R; Vittori M; Cipriani C; Maiorino F; Forte V; Iacovelli V; Petta F; Sperandio M; Marani C; Panei M; Travaglia S; Bove P
Prog Urol; 2021 Oct; 31(12):739-746. PubMed ID: 33431200
[TBL] [Abstract][Full Text] [Related]
8. Clinical study of multifactorial diagnosis in prostate biopsy.
Li J; Wang K; Li S; Wu P; Wang X; He Y; Tang W
Prostate; 2023 Nov; 83(15):1494-1503. PubMed ID: 37545333
[TBL] [Abstract][Full Text] [Related]
9. Histology core-specific evaluation of the European Society of Urogenital Radiology (ESUR) standardised scoring system of multiparametric magnetic resonance imaging (mpMRI) of the prostate.
Kuru TH; Roethke MC; Rieker P; Roth W; Fenchel M; Hohenfellner M; Schlemmer HP; Hadaschik BA
BJU Int; 2013 Dec; 112(8):1080-7. PubMed ID: 23937255
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a Cascaded Deep Learning-based Algorithm for Prostate Lesion Detection at Biparametric MRI.
Lin Y; Yilmaz EC; Belue MJ; Harmon SA; Tetreault J; Phelps TE; Merriman KM; Hazen L; Garcia C; Yang D; Xu Z; Lay NS; Toubaji A; Merino MJ; Xu D; Law YM; Gurram S; Wood BJ; Choyke PL; Pinto PA; Turkbey B
Radiology; 2024 May; 311(2):e230750. PubMed ID: 38713024
[TBL] [Abstract][Full Text] [Related]
11. Detection of Gleason 6 prostate cancer in patients with clinically significant prostate cancer on multiparametric magnetic resonance imaging.
Chaloupka M; Bischoff R; Pfitzinger P; Lellig E; Ledderose S; Buchner A; Schlenker B; Stief C; Clevert DA; Apfelbeck M
Clin Hemorheol Microcirc; 2019; 73(1):105-111. PubMed ID: 31561351
[TBL] [Abstract][Full Text] [Related]
12. Multicenter Multireader Evaluation of an Artificial Intelligence-Based Attention Mapping System for the Detection of Prostate Cancer With Multiparametric MRI.
Mehralivand S; Harmon SA; Shih JH; Smith CP; Lay N; Argun B; Bednarova S; Baroni RH; Canda AE; Ercan K; Girometti R; Karaarslan E; Kural AR; Purysko AS; Rais-Bahrami S; Tonso VM; Magi-Galluzzi C; Gordetsky JB; Macarenco RSES; Merino MJ; Gumuskaya B; Saglican Y; Sioletic S; Warren AY; Barrett T; Bittencourt L; Coskun M; Knauss C; Law YM; Malayeri AA; Margolis DJ; Marko J; Yakar D; Wood BJ; Pinto PA; Choyke PL; Summers RM; Turkbey B
AJR Am J Roentgenol; 2020 Oct; 215(4):903-912. PubMed ID: 32755355
[No Abstract] [Full Text] [Related]
13. Prostate Indeterminate Lesions on Magnetic Resonance Imaging-Biopsy Versus Surveillance: A Literature Review.
Gómez Rivas J; Giganti F; Álvarez-Maestro M; Freire MJ; Kasivisvanathan V; Martinez-Piñeiro L; Emberton M
Eur Urol Focus; 2019 Sep; 5(5):799-806. PubMed ID: 29525382
[TBL] [Abstract][Full Text] [Related]
14. Structured approach to resolving discordance between PI-RADS v2.1 score and targeted prostate biopsy results: an opportunity for quality improvement.
Arcot R; Sekar S; Kotamarti S; Krischak M; Michael ZD; Foo WC; Huang J; Polascik TJ; Gupta RT
Abdom Radiol (NY); 2022 Aug; 47(8):2917-2927. PubMed ID: 35674785
[TBL] [Abstract][Full Text] [Related]
15. Multiparametric Magnetic Resonance Imaging Second Opinion May Reduce the Number of Unnecessary Prostate Biopsies: Time to Improve Radiologists' Training Program?
Luzzago S; Petralia G; Musi G; Catellani M; Alessi S; Di Trapani E; Mistretta FA; Serino A; Conti A; Pricolo P; Nazzani S; Mirone V; Matei DV; Montanari E; de Cobelli O
Clin Genitourin Cancer; 2019 Apr; 17(2):88-96. PubMed ID: 30527286
[TBL] [Abstract][Full Text] [Related]
16. Comparison of prostate cancer detection rate at targeted biopsy of hub and spoke centers mpMRI: experience matters.
Droghetti M; Bianchi L; Gaudiano C; Corcioni B; Rustici A; Piazza P; Beretta C; Balestrazzi E; Costa F; Feruzzi A; Salvador M; Giunchi F; Fiorentino M; Golfieri R; Schiavina R; Brunocilla E
Minerva Urol Nephrol; 2023 Feb; 75(1):42-49. PubMed ID: 35766364
[TBL] [Abstract][Full Text] [Related]
17. The Accuracy of Prostate Magnetic Resonance Imaging Interpretation: Impact of the Individual Radiologist and Clinical Factors.
Pickersgill NA; Vetter JM; Raval NS; Andriole GL; Shetty AS; Ippolito JE; Kim EH
Urology; 2019 May; 127():68-73. PubMed ID: 30807773
[TBL] [Abstract][Full Text] [Related]
18. Optimizing Combined Magnetic Resonance Imaging (MRI)-Targeted and Systematic Biopsy Strategies: Sparing the Multiparametric MRI-Negative Transitional Zone in Presence of Exclusively Peripheral Multiparametric MRI-Suspect Lesions.
Kachanov M; Leyh-Bannurah SR; Roberts MJ; Sauer M; Beyersdorff D; Boiko S; Maurer T; Steuber T; Graefen M; Budäus L
J Urol; 2022 Feb; 207(2):333-340. PubMed ID: 34555925
[TBL] [Abstract][Full Text] [Related]
19. Evolution of Targeted Prostate Biopsy by Adding Micro-Ultrasound to the Magnetic Resonance Imaging Pathway.
Wiemer L; Hollenbach M; Heckmann R; Kittner B; Plage H; Reimann M; Asbach P; Friedersdorff F; Schlomm T; Hofbauer S; Cash H
Eur Urol Focus; 2021 Nov; 7(6):1292-1299. PubMed ID: 32654967
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Pathway with Multiparametric Magnetic Resonance Imaging Versus Standard Pathway: Results from a Randomized Prospective Study in Biopsy-naïve Patients with Suspected Prostate Cancer.
Porpiglia F; Manfredi M; Mele F; Cossu M; Bollito E; Veltri A; Cirillo S; Regge D; Faletti R; Passera R; Fiori C; De Luca S
Eur Urol; 2017 Aug; 72(2):282-288. PubMed ID: 27574821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
